Drugs / Q8003
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00831051 | Dec 2008 → Jan 2009 | — | QRxPharma Inc. | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT00565760 | Nov 2007 → Mar 2008 | — | QRxPharma Inc. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Q8003 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00565760 ↗ |